ÂÜÀòÂÒÂ×

Donna Flesher is an accomplished professional in the field of biomarker and bioanalytical sciences with extensive experience in both leadership roles and scientific research. Currently serving as the Head of Biomarker and Bioanalytical Sciences at Biogen since September 2024, Donna previously held significant positions, including Chair of the Board of Directors at HIBio and Head of Oncology Clinical Biomarkers at Amgen. With a strong educational background, including a Ph.D. in Immunology from Stanford University, Donna has contributed to various organizations, such as Rape Trauma Services of San Mateo County as a Board of Directors Member. Additionally, Donna has teaching experience as an instructor at UC Berkeley Extension and has conducted postdoctoral research at Genentech, further solidifying a robust career in the health sciences and biotechnology sectors.